Open Menu
News & events

News

  • Post date

  • Tags

  • By author

Advanced search
September 16, 2009 Cambrex Continuous-Flow Microwave Assisted Synthesis Technology Nominated for 2009 Innovations Award
August 24, 2009 Cambrex Receives FDA Warning Letter
March 13, 2009 Cambrex Opened New $20 Million cGMP Plant on March 6, 2009
May 15, 2008 Cambrex Appoints Steven M. Klosk as President and CEO
March 21, 2008 Cambrex Customer Announced Recall
January 7, 2008 Cambrex Signs Agreement to Acquire ProSyntest AS
February 13, 2007 Cambrex Announces Investment at Karlskoga Site
February 9, 2007 Cambrex Announces New Leadership Team
February 6, 2007 Cambrex Completes Sale of Bio Business
January 26, 2007 Cambrex Corporation Reports Quarterly Dividend
January 5, 2007 Cambrex Shareholders Approve Sale of Bio Business

About us

Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle

Quality & regulatory

We deliver quality in every aspect of our work, across all of our facilities, systems and teams

Environment, health & safety

Our strong commitment to the environment and health and safety underpins all that we do at Cambrex

Cambrex careers

At Cambrex, it’s our people that set us apart. We’re committed to attracting, nurturing and retaining a passionate and talented team of experts that enjoy what they do